“Direct Oral Anticoagulants’ Effectiveness and Safety in Pediatric Patients Compared to Standard Care”

https://pubmed.ncbi.nlm.nih.gov/38117441

Direct oral anticoagulants (DOACs) reduce the risk of venous thromboembolism (VTE) in pediatric patients without increasing the risk of bleeding, all-cause mortality, or serious adverse events compared to standard-of-care anticoagulants.